is saxenda a glp 1 drug (liraglutide) Liraglutide: Uses, Side Effects, Dosages,

Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors

Policy and Implementation Research Countries with experience in navigating GLP-1 receptor agonist coverage decisions for people with obesity offer lessons for others now facing similar decisions or reconsidering their existing policies [86]

Similarly, Firkins et al

Dixit AA, Bateman BT, Hawn MT, Odden MC, Sun EC

While real-world data on the level of adherence to dual GLP1-RA/GIP agonists are not available to date, some considerations can be drawn from available clinical trials and experiences with other pharmacological classes

They should not be used in people with type 1 diabetes or for the treatment of diabetic ketoacidosis